Ignite Creation Date:
2024-05-06 @ 7:09 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05911061
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-23
First Post:
2023-06-19
Brief Title:
A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent XBBBA5Delta Protein Vaccine Sf9 Cell in Booster Vaccination
Sponsor:
WestVac Biopharma Co Ltd
Organization:
WestVac Biopharma Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-07-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-19
First Submit QC Date:
June 19 2023
Study First Post Date:
2023-06-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-23
Last Update Post Date:
2024-04-23
Last Update Post Date Type:
ACTUAL